This week, fast-food king-pin McDonald’s (NYSE:MCD) unveiled in Japan its newest creation- Mega Fries. The three-quarters of a pound, 1142 calorie serving of french fries- while potentially delicious- underscores that our new diet of convenience and excess is having some sobering effects on our heaths. As the world moves towards less physical activity and increased consumption of nutritionally deficient foods with higher levels of sugar and saturated fats, obesity rates and its complications will continue to rise, globally.
Incidences of one of those complications- diabetes- is rising at an exponential pace.
For investors, we can find opportunities in this sobering statistic in the companies that are working towards a cure or treat diabetes. 

A Growing Global Problem 
The National Institute of Health estimates that obesity and related complications such as diabetes are our nation's chief health concern. However, while most people tend to think of diabetes and obesity as a developed market problem, the two issues are spreading quite rapidly across the globe. Roughly, four out of five people suffering from diabetes are now located in developing markets. China alone, has 92.3 million diabetic citizens, while India’s diabetic population is over 50 million. Overall, there are nearly 371 million people across the globe that suffer from diabetes and plenty more that are in pre-diabetic stages.
However, there ranks are growing quite rapidly.
According to a new report from The International Diabetes Federation (IDF), at least one in 10 adults will have diabetes by 2030. Based on factors like aging, demographic changes, diet changes and increasing sedentary lifestyles, the group predicts that an estimated 552 million people could have diabetes in less than two decades' time. Overall, the IDF expects the number of cases to jump by 90% with the biggest contributor of new cases coming from the emerging world. This new report echoes similar statements made by the World Health Organization and Centers For Disease Control.  
All in all, the growing number of people who suffer from the disease will push the global spending for diabetes to reach $48 to $53 billion by 2016. That’s some serious spending amounts and could be lucrative opportunity for investors.
A Diabetes Portfolio 
Given just how big of an epidemic that diabetes has become, investors may want to contribute some capital to the sector. Many major pharmaceutical firms like Eli Lilly (NYSE:LLY) or Sanofi (NYSE: SNY) have divisions devoted to diabetes care and treatment. However, some of the best opportunities could be in the firms that specialize in the diseases care.
While there are several new therapy's in the works for diabetes care- such as MannKind’s (NASDAQ: MNKD) inhaled insulin drug Afrezza- injectable insulin still remains at the bread and butter of the industry. Novo Nordisk (NYSE:NVO) became one of the first manufacturers of insulin in 1923 and currently supplies more than half of the world’s dosage. The position is being strengthened in the emerging world as Novo has undergone a pricing strategy-in places like Africa and India- that helps get its insulin products into the hands of the poor for dirt cheap. Given the population sizes of these markets, Novo believes that over time volume of insulin sold will lead to serious profits. As such, investors may want to go with the leader in the space.
The diabetes sub-sector is the largest market for medical devices. Analysts estimate that in the U.S. alone will reach $20 billion by next year. Investors can play the device angle through several avenues from syringe manufacturers like Retractable Technologies (NYSE:RVP) and West Pharmaceutical (NYSE:WST), glucose monitors through Becton, Dickinson and Company (NYSE:BDX) or cutting edge insulin pumps through Insulet Corporation (NASDAQ: PODD).
Finally, one of the sad potential side-effects of diabetes is kidney failure and millions of people around the world suffer from this condition. DaVita (NYSE:DVA) owns and operate kidney dialysis centers with primarily focus on the United States. The company’s future potential hasn’t gone unnoticed as America’s favorite value investors- Warren Buffett- has taken a sizable stake in the firm. Incidentally, Buffett also holds a stake in Becton; Dickinson. Retail investors may want to follow suit as the epidemic continues to grow.
The Bottom Line
Sadly, diabetes is quickly becoming a global epidemic. As inactivity and high fat diets continue to seep into our lifestyles, the problems will compound themselves. Within these grim statistics, investors can find opportunities with the companies that are fighting this epidemic. The previous stocks represent a good starting point for further research.

Related Articles
  1. Mutual Funds & ETFs

    Top 5 Health Mutual Funds

    Learn about the top five mutual funds that invest in stocks of companies that primarily operate in the health care sector of the United States.
  2. Mutual Funds & ETFs

    What Exactly Are Arbitrage Mutual Funds?

    Learn about arbitrage funds and how this type of investment generates profits by taking advantage of price differentials between the cash and futures markets.
  3. Investing News

    Ferrari’s IPO: Ready to Roll or Poor Timing?

    Will Ferrari's shares move fast off the line only to sputter later?
  4. Stock Analysis

    5 Cheap Dividend Stocks for a Bear Market

    Here are five stocks that pay safe dividends and should be at least somewhat resilient to a bear market.
  5. Investing

    How to Win More by Losing Less in Today’s Markets

    The further you fall, the harder it is to climb back up. It’s a universal truth that is painfully apparent in the investing world.
  6. Fundamental Analysis

    Use Options Data To Predict Stock Market Direction

    Options market trading data can provide important insights about the direction of stocks and the overall market. Here’s how to track it.
  7. Stock Analysis

    2 Oil Stocks to Buy Right Now (PSX,TSO)

    Can these two oil stocks buck the trend?
  8. Investing News

    What Alcoa’s (AA) Breakup Means for Investors

    Alcoa plans to split into two companies. Is this a bullish catalyst for investors?
  9. Stock Analysis

    Top 3 Stocks for the Coming Holiday Season

    If you want to buck the bear market trend by going long on consumer stocks, these three might be your best bets.
  10. Investing News

    Could a Rate Hike Send Stocks Higher?

    A rate hike would certainly alter the investment scene, but would it be for the better or worse?
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!